FLT1 anticorps (AA 31-35)
Aperçu rapide pour FLT1 anticorps (AA 31-35) (ABIN871731)
Antigène
Voir toutes FLT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 31-35
-
Specificité
- The antibody detects endogenous level of total VEGFR1 protein.
-
Purification
- Affinity purified
-
Immunogène
- Peptide sequence around AA 31-35 (D-P-E-L-S) derived from Human VEGFR1. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
-
-
-
-
Indications d'application
- Western blotting: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
-
Autre désignation
- VEGFR1
-
Sujet
- Receptor for VEGF, VEGFB and PGF. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. Isoform SFlt1 may have an inhibitory role in angiogenesis.
-
Poids moléculaire
- 180 kDa
-
ID gène
- 2321
-
NCBI Accession
- NP_002010
-
UniProt
- P17948
-
Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Antigène
-